Honora Englander1,2, Alisa Patten3, Rachel Lockard4, Matthew Muller5, Jessica Gregg3,6. 1. Division of Hospital Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA. englandh@ohsu.edu. 2. Section of Addiction Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA. englandh@ohsu.edu. 3. Section of Addiction Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA. 4. School of Medicine, Oregon Health & Science University, Portland, OR, USA. 5. Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA. 6. Division of General Internal Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
Abstract
BACKGROUND: Despite evidence of effectiveness, most US hospitals do not deliver hospital-based addictions care. ECHO (Extension for Community Healthcare Outcomes) is a telementoring model for providers across diverse geographic areas. We developed and implemented a substance use disorder (SUD) in hospital care ECHO to support statewide dissemination of best practices in hospital-based addictions care. OBJECTIVES: Assess the feasibility, acceptability, and effects of ECHO and explore lessons learned and implications for the spread of hospital-based addictions care. DESIGN: Mixed-methods study with a pre-/post-intervention design. PARTICIPANTS: Interprofessional hospital providers and administrators across Oregon. INTERVENTION: A 10-12-week ECHO that included participant case presentations and brief didactics delivered by an interprofessional faculty, including peers with lived experience in recovery. APPROACH: To assess feasibility and acceptability, we collected enrollment, attendance, and participant feedback data. To evaluate ECHO effects, we used pre-/post-ECHO assessments and performed a thematic analysis of open-ended survey responses and participant focus groups. KEY RESULTS: We recruited 143 registrants to three cohorts between January and September 2019, drawing from 32 of Oregon's 62 hospitals and one southwest Washington hospital. Ninety-six (67.1%) attended at least half of ECHO sessions. Participants were highly satisfied with ECHO. After ECHO, participants were more prepared to treat SUD; however, prescribing did not change. Participants identified substantial gains in knowledge and skills, particularly regarding the use of medications for opioid use disorder; patient-centered communication with people who use drugs; and understanding harm reduction as a valid treatment approach. ECHO built a community of practice and reduced provider isolation. Participants recognized the need for supportive hospital leadership, policies, and SUD resources to fully implement and adopt hospital-based SUD care. CONCLUSIONS: A statewide, interprofessional SUD hospital care ECHO was feasible and acceptable. Findings may be useful to health systems, states, and regions looking to expand hospital-based addictions care.
BACKGROUND: Despite evidence of effectiveness, most US hospitals do not deliver hospital-based addictions care. ECHO (Extension for Community Healthcare Outcomes) is a telementoring model for providers across diverse geographic areas. We developed and implemented a substance use disorder (SUD) in hospital care ECHO to support statewide dissemination of best practices in hospital-based addictions care. OBJECTIVES: Assess the feasibility, acceptability, and effects of ECHO and explore lessons learned and implications for the spread of hospital-based addictions care. DESIGN: Mixed-methods study with a pre-/post-intervention design. PARTICIPANTS: Interprofessional hospital providers and administrators across Oregon. INTERVENTION: A 10-12-week ECHO that included participant case presentations and brief didactics delivered by an interprofessional faculty, including peers with lived experience in recovery. APPROACH: To assess feasibility and acceptability, we collected enrollment, attendance, and participant feedback data. To evaluate ECHO effects, we used pre-/post-ECHO assessments and performed a thematic analysis of open-ended survey responses and participant focus groups. KEY RESULTS: We recruited 143 registrants to three cohorts between January and September 2019, drawing from 32 of Oregon's 62 hospitals and one southwest Washington hospital. Ninety-six (67.1%) attended at least half of ECHO sessions. Participants were highly satisfied with ECHO. After ECHO, participants were more prepared to treat SUD; however, prescribing did not change. Participants identified substantial gains in knowledge and skills, particularly regarding the use of medications for opioid use disorder; patient-centered communication with people who use drugs; and understanding harm reduction as a valid treatment approach. ECHO built a community of practice and reduced provider isolation. Participants recognized the need for supportive hospital leadership, policies, and SUD resources to fully implement and adopt hospital-based SUD care. CONCLUSIONS: A statewide, interprofessional SUD hospital care ECHO was feasible and acceptable. Findings may be useful to health systems, states, and regions looking to expand hospital-based addictions care.
Entities:
Keywords:
ECHO model; case-based learning; continuing medical education; hospitalization; substance use treatment; substance-related disorders
Authors: Miriam Komaromy; Venice Ceballos; Andrea Zurawski; Thomas Bodenheimer; David H Thom; Sanjeev Arora Journal: J Public Health Policy Date: 2018-05 Impact factor: 2.222
Authors: Sarah E Wakeman; Joshua P Metlay; Yuchiao Chang; Grace E Herman; Nancy A Rigotti Journal: J Gen Intern Med Date: 2017-05-19 Impact factor: 5.128
Authors: Marc R Larochelle; Ryan Bernstein; Dana Bernson; Thomas Land; Thomas J Stopka; Adam J Rose; Monica Bharel; Jane M Liebschutz; Alexander Y Walley Journal: Drug Alcohol Depend Date: 2019-09-03 Impact factor: 4.492
Authors: Honora Englander; Konrad Dobbertin; Bonnie K Lind; Christina Nicolaidis; Peter Graven; Claire Dorfman; P Todd Korthuis Journal: J Gen Intern Med Date: 2019-12 Impact factor: 5.128
Authors: Matthew O'Donnell; Honora Englander; Luke Strnad; Castigliano M Bhamidipati; Evan Shalen; Patricio A Riquelme Journal: J Gen Intern Med Date: 2022-01-11 Impact factor: 5.128
Authors: Caroline A King; Ryan Cook; Haven Wheelock; P Todd Korthuis; Judith M Leahy; Amelia Goff; Cynthia D Morris; Honora Englander Journal: Int J Drug Policy Date: 2021-11-24
Authors: Caroline A King; Ryan Cook; P Todd Korthuis; Dennis McCarty; Cynthia D Morris; Honora Englander Journal: J Addict Med Date: 2022-02-08 Impact factor: 4.647